JPS59130816A - 医薬組成物 - Google Patents

医薬組成物

Info

Publication number
JPS59130816A
JPS59130816A JP58252434A JP25243483A JPS59130816A JP S59130816 A JPS59130816 A JP S59130816A JP 58252434 A JP58252434 A JP 58252434A JP 25243483 A JP25243483 A JP 25243483A JP S59130816 A JPS59130816 A JP S59130816A
Authority
JP
Japan
Prior art keywords
group
hydrogen
ace inhibitor
composition according
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58252434A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6225645B2 (enExample
Inventor
ロバ−ト・ウエイン・ワトキンズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schering Plough Corp
Original Assignee
Schering Plough Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Corp filed Critical Schering Plough Corp
Publication of JPS59130816A publication Critical patent/JPS59130816A/ja
Publication of JPS6225645B2 publication Critical patent/JPS6225645B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
JP58252434A 1982-12-27 1983-12-27 医薬組成物 Granted JPS59130816A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45325782A 1982-12-27 1982-12-27
US453257 1982-12-27

Publications (2)

Publication Number Publication Date
JPS59130816A true JPS59130816A (ja) 1984-07-27
JPS6225645B2 JPS6225645B2 (enExample) 1987-06-04

Family

ID=23799812

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58252434A Granted JPS59130816A (ja) 1982-12-27 1983-12-27 医薬組成物

Country Status (4)

Country Link
EP (1) EP0114333B1 (enExample)
JP (1) JPS59130816A (enExample)
AT (1) ATE55911T1 (enExample)
DE (1) DE3381850D1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63500306A (ja) * 1985-07-03 1988-02-04 シェリング・コ−ポレ−ション 抗緑内障組成物
JPS63132835A (ja) * 1986-11-03 1988-06-04 サンド・アクチエンゲゼルシャフト 高血圧およびうっ血性心不全用医薬組成物

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410732A1 (de) * 1984-03-23 1985-09-26 Hoechst Ag, 6230 Frankfurt Methode zur behandlung des glaukoms
US4885293A (en) * 1984-09-24 1989-12-05 Schering Corporation Antiglaucoma agents
US4914090A (en) * 1985-11-01 1990-04-03 Schering Corporation Ophthalmic compositions
US5346887A (en) * 1987-10-06 1994-09-13 Abbott Laboratories Glaucoma treatment
US5036051A (en) * 1987-10-06 1991-07-30 Abbott Laboratories Glaucoma treatment
US4927807A (en) * 1987-10-06 1990-05-22 Abbott Laboratories Glaucoma treatment
US5059589A (en) * 1988-09-08 1991-10-22 Abbott Laboratories Glaucoma treatment
EP0375319A3 (en) * 1988-12-19 1991-12-11 Merck & Co. Inc. Angiotensin converting enzyme inhibitors in the treatment of glaucoma
US5688770A (en) * 1989-12-14 1997-11-18 Schering Corporation Antiglaucoma compositions and methods
WO1999036062A1 (en) * 1998-01-16 1999-07-22 Alcon Laboratories, Inc. Topical administration of angiotensin-converting enzyme inhibitors
FR2794975A1 (fr) * 1999-06-16 2000-12-22 Raouf Rekik Medicaments opthalmologiques neuro et retino-protecteurs
PL352365A1 (en) 1999-06-16 2003-08-25 Rekik Elyes Ben Mohamed Raouf Neuroprotective and retinoprotective ophthalmologic medicines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046889A (en) * 1976-02-13 1977-09-06 E. R. Squibb & Sons, Inc. Azetidine-2-carboxylic acid derivatives
DE3174844D1 (en) * 1980-10-23 1986-07-24 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63500306A (ja) * 1985-07-03 1988-02-04 シェリング・コ−ポレ−ション 抗緑内障組成物
JPS63132835A (ja) * 1986-11-03 1988-06-04 サンド・アクチエンゲゼルシャフト 高血圧およびうっ血性心不全用医薬組成物

Also Published As

Publication number Publication date
DE3381850D1 (de) 1990-10-04
ATE55911T1 (de) 1990-09-15
EP0114333A3 (en) 1985-08-14
EP0114333A2 (en) 1984-08-01
EP0114333B1 (en) 1990-08-29
JPS6225645B2 (enExample) 1987-06-04

Similar Documents

Publication Publication Date Title
US5134124A (en) Use of a statin derivative in the treatment of eye complaints
JPS59130816A (ja) 医薬組成物
EP0743852A1 (en) Treatment of normotensive glaucoma with angiotensin ii antagonists
US5438060A (en) Method of reducing elevated intraocular pressure
US4309432A (en) Compositions for treating glaucoma containing a carbostyril
IL259562A (en) Aminophosphinic derivatives for preventing and treating eye pain
JP2527513B2 (ja) 炭酸脱水酵素阻害物質とβ−アドレナリン拮抗剤との組合せを含有する眼科薬組成物
WO1999018969A1 (en) Remedial composition for intraocular hypertension or glaucoma
US5965620A (en) Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
EP0420606B1 (en) Use of 2-cycloalkylamino oxazolines for reducing or maintaining intraocular pressure
AU590315B2 (en) Antiglaucoma compositions
US5308849A (en) Method of reducing elevated intraocular pressure
US4826812A (en) Antiglaucoma agent
EP0375299A1 (en) Combinations of angiotensin converting enzyme, and carbonic anhydrase, inhibitors for treating glaucoma
JPS60115520A (ja) 眼性高血圧症の治療のための末梢的に選択的なドーパミン拮抗物質
JPH01128920A (ja) 眼圧低下剤
US4322425A (en) Compositions for treating glaucoma
EP0728480A1 (en) Use of ifenprodil for treatment of elevated intraocular pressure
EP0277814B1 (en) Anti-glaucoma use of trifluoromethanesulfonamide
US5428030A (en) Method of reducing elevated intraocular pressure
EP0375319A3 (en) Angiotensin converting enzyme inhibitors in the treatment of glaucoma
JPH0778022B2 (ja) 緑内障治療剤
IE904261A1 (en) Use of a statin derivative in the treatment of eye¹complaints
GB2077102A (en) Ophthalmic compositions